Glaucoma, a leading cause of irreversible blindness worldwide, necessitates effective and reliable treatment solutions. At the forefront of ophthalmic pharmaceutical innovation is Latanoprost API, a critical component in many advanced treatments. As a prominent manufacturer and supplier of Latanoprost API, we understand its profound impact on patient outcomes and the importance of a stable, high-quality supply chain.

Latanoprost, chemically known as Isopropyl (5Z,9α,11α,15R)-9,11,15-trihydroxy-17-phenyl-18,19,20-trinor-prost-5-en-1-oate, with CAS number 130209-82-4, is a synthetic prostaglandin F2α analog. Its therapeutic efficacy stems from its action as a selective agonist for the prostaglandin F2α receptor (FP receptor). When formulated into ophthalmic solutions, Latanoprost acts as a prodrug. This means it is an inactive substance that is readily absorbed through the cornea and then rapidly hydrolyzed by esterases in the aqueous humor of the eye into its biologically active free acid form. This active metabolite is responsible for increasing the uveoscleral outflow of aqueous humor, thereby effectively reducing intraocular pressure (IOP).

The mechanism of action is crucial for its application in treating open-angle glaucoma and ocular hypertension. Unlike older treatments that might primarily reduce aqueous humor production, Latanoprost enhances the natural drainage pathway, offering a different therapeutic approach. This selective action and prodrug design contribute to its favorable safety profile and efficacy, making it a first-line treatment option for many patients.

For pharmaceutical companies and researchers, sourcing high-purity Latanoprost API is paramount. Variations in purity or the presence of related substances can significantly impact the safety and efficacy of the final ophthalmic product. Our commitment as a leading manufacturer in China is to provide Latanoprost API that meets the most stringent international pharmaceutical standards. We ensure rigorous quality control throughout our manufacturing process, from raw material sourcing to final product release, guaranteeing a product with ≥99.0% assay and controlled levels of impurities.

When considering the purchase of Latanoprost API, factors such as price, availability, and the reliability of the manufacturer are key. We understand the critical nature of pharmaceutical supply chains and strive to offer competitive pricing for bulk orders of Latanoprost API. Our robust production capacity and efficient logistics enable us to provide a secure and consistent supply, ensuring that our clients can meet the demands of their markets. Whether you are developing new ophthalmic formulations or require a steady supply of this essential API for existing products, we are equipped to be your trusted partner.

We encourage procurement managers and R&D scientists to inquire about our Latanoprost API. By choosing us as your supplier, you are investing in quality, reliability, and cost-effectiveness, contributing to the development and availability of vital treatments for millions suffering from glaucoma and ocular hypertension. Contact us today to discuss your requirements and request a quote or sample of our high-purity Latanoprost API.